Hongkongers Start Receiving BioNTech Jabs
"); jQuery("#212 h3").html("

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1579748_1_20210310182932.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1579748-20210310.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1579748-20210310.htm', 'DCS.dcsqry', '' ); } } }); }); });
2021-03-10 HKT 13:14
Hong Kong on Wednesday began inoculating people against coronavirus with Germany's BioNTech vaccine, with some of those first in the queue saying they believe it will be safer and more effective than the Sinovac jab also available.
Seven centres – in Sai Ying Pun, Sai Wan Ho, Kowloon Tong, Kwun Tong, Lai Chi Kok, Sheung Shui and Yuen Long are now providing the BioNTech jabs, for priority groups at first.
Many of those who had booked appointments at the Kowloon Tong centre on Wednesday were foreign residents. People RTHK spoke to said they were confident about receiving the vaccine.
“I’m not afraid at all. Not at all. Because they have a full medical report published, and millions and millions of people abroad have already taken the jabs. I know there are no serious side effects,” said an 80-year-old man.
A pharmacist surnamed Lam agreed that any side effects should be mild.
"From overseas experience, this vaccine is also used in high risk groups, for the elderly and also people with chronic diseases. I have confidence in this vaccine," she said.
A 76-year-old man surnamed Azim said he was not concerned about having an adverse reaction to the jab.
“I’m in good health, so no problem for me,” he laughed.
“We were told that Pfizer/BioNTech is the best. Pfizer has more efficacy,” he added.
A man surnamed Lam, meanwhile, said he didn't want to take the Sinovac jab after seeing news reports about deaths and hospitalisations among people who had received it.
“I’m not confident about it. You can see on the news, one case after another. If I’m unlucky, I might be one of them,” he said.
Authorities and experts have said they don't believe the recent deaths were linked to the Sinovac jabs, and some of those taking the BioNTech vaccine on Wednesday said they would have preferred to get the China-made vaccine, but couldn't get an appointment slot.
Most of the people RTHK spoke to said they felt fine after having the BioNTech jab. They will need to take a second dose after three weeks.
Treasury Secretary Grilled On Economic Figures And Foreign Policy. He Refrained From Directly Calling Ukraine An Ally.
Treasury Secretary Scott Bessent emphasized that prices would come down as soon as the Iran war ended, hailed Trump's ec... Read more
More Than Seven In Ten Americans Think The U.S. Is On The 'Wrong Track' Ahead Of The Midterms: Poll
The new poll also showed that Trump's approval rating had sunk to 34%, with more than half of respondents saying they "s... Read more
World Bank Encourages Developing Nations To Embrace 'Small' AI To Accelerate Economic Growth
Paschal Donohoe, the managing director and chief knowledge officer at the World Bank, said that so-called "small AI" cou... Read more
Ukraine Launches Large-Scale Drone Attack On Russia, Defies Trump's Demands To Leave Russian Energy Alone
Swarms of Ukrainian drones hit numerous targets in Russia, including an oil terminal, overnight despite Trump's repeated... Read more
Protests In France Are Becoming Increasingly Violent. Demonstrations Have Now Spread To Other European Countries.
The protests, which began as localized demonstrations against perceived neglect in the French education system, intensif... Read more
Trump Maintains Defiant Message In Kentucky Midterm Rally, Makes Dubious Claims About Republican Popularity
The president held a rally on Saturday in which he touted the supposed successes of his two terms in office, attacked hi... Read more